Efficacy and safety of grasping forceps-assisted endoscopic resection for gastric neoplasms: A multi-centre retrospective study.
Endoscopic mucosal resection
Endoscopic resection
Endoscopic submucosal dissection
Gastric cancer
Grasping forceps-assisted endoscopic resection
Journal
World journal of gastrointestinal oncology
ISSN: 1948-5204
Titre abrégé: World J Gastrointest Oncol
Pays: China
ID NLM: 101532470
Informations de publication
Date de publication:
15 Mar 2021
15 Mar 2021
Historique:
received:
10
12
2020
revised:
09
01
2021
accepted:
01
02
2021
entrez:
19
3
2021
pubmed:
20
3
2021
medline:
20
3
2021
Statut:
ppublish
Résumé
Endoscopic submucosal dissection (ESD) is widely accepted for early gastric cancer (EGC) without lymph node metastasis, although ESD is challenging, even for small lesions, in the greater curvature (GC) of the upper (U) and middle (M) thirds of the stomach. Grasping forceps-assisted endoscopic resection (GF-ER) is a type of endoscopic mucosal resection that is performed To investigate the safety and efficacy of GF-ER We retrospectively reviewed the medical records of 506 patients who underwent ER of 522 EGC lesions in the stomach's U and M regions in three institutions between January 2016 and May 2020. Nine lesions from eight patients who underwent GF-ER for EGC (the GF-ER group) were compared to 63 lesions from 63 patients who underwent ESD (the ESD group). We also performed a subgroup analysis of small lesions (≤ 10 mm) in 6 patients (7 lesions) from the GF-ER group and 20 patients (20 lesions) from the ESD group. There were no statistically significant differences between the GF-ER and ESD groups in the These findings suggest that GF-ER may be an effective therapeutic option for small lesions in the GC of the stomach's U and M regions.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic submucosal dissection (ESD) is widely accepted for early gastric cancer (EGC) without lymph node metastasis, although ESD is challenging, even for small lesions, in the greater curvature (GC) of the upper (U) and middle (M) thirds of the stomach. Grasping forceps-assisted endoscopic resection (GF-ER) is a type of endoscopic mucosal resection that is performed
AIM
OBJECTIVE
To investigate the safety and efficacy of GF-ER
METHODS
METHODS
We retrospectively reviewed the medical records of 506 patients who underwent ER of 522 EGC lesions in the stomach's U and M regions in three institutions between January 2016 and May 2020. Nine lesions from eight patients who underwent GF-ER for EGC (the GF-ER group) were compared to 63 lesions from 63 patients who underwent ESD (the ESD group). We also performed a subgroup analysis of small lesions (≤ 10 mm) in 6 patients (7 lesions) from the GF-ER group and 20 patients (20 lesions) from the ESD group.
RESULTS
RESULTS
There were no statistically significant differences between the GF-ER and ESD groups in the
CONCLUSION
CONCLUSIONS
These findings suggest that GF-ER may be an effective therapeutic option for small lesions in the GC of the stomach's U and M regions.
Identifiants
pubmed: 33738045
doi: 10.4251/wjgo.v13.i3.174
pmc: PMC7953346
doi:
Types de publication
Journal Article
Langues
eng
Pagination
174-184Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare that they have no conflict-of-interests.
Références
BMJ Open. 2019 Dec 23;9(12):e025803
pubmed: 31874864
Gastric Cancer. 2007;10(1):1-11
pubmed: 17334711
Hepatogastroenterology. 2004 Jan-Feb;51(55):269-72
pubmed: 15011883
Gut. 2009 Mar;58(3):331-6
pubmed: 19001058
Dig Endosc. 2019 Jan;31(1):30-39
pubmed: 30058258
Gastrointest Endosc. 2009 Jun;69(7):1228-35
pubmed: 19249769
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Endoscopy. 2019 Mar;51(3):279-280
pubmed: 30634193
Gastrointest Endosc. 2016 Feb;83(2):337-46
pubmed: 26320698
Am J Gastroenterol. 2016 Feb;111(2):240-9
pubmed: 26782817
Gastrointest Endosc. 1991 Mar-Apr;37(2):128-32
pubmed: 2032596
Surg Endosc. 1991;5(4):182-4
pubmed: 1805394
Gastric Cancer. 2017 Jan;20(1):1-19
pubmed: 27342689
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
Gastrointest Endosc. 2006 Dec;64(6):877-83
pubmed: 17140890
Gastrointest Endosc. 1999 Feb;49(2):192-9
pubmed: 9925697
Gastrointest Endosc. 1999 Jul;50(1):95-8
pubmed: 10385732
World J Gastroenterol. 2019 Jul 28;25(28):3764-3774
pubmed: 31391771
Gastrointest Endosc. 2011 Feb;73(2):349-52
pubmed: 21295646
Dig Endosc. 2011 Oct;23(4):296-301
pubmed: 21951089
Endosc Int Open. 2019 Feb;7(2):E298-E301
pubmed: 30746432
Endoscopy. 2006 Oct;38(10):987-90
pubmed: 17058162